(PharmaNewsWire.Com, July 31, 2017 ) Publisher's clinical trial report, "Bullous Pemphigoid Global Clinical Trials Review, H1, 2017" provides an overview of Bullous Pemphigoid clinical trials scenario. This report provides top line data relating to the clinical trials on Bullous Pemphigoid. Report...
(PharmaNewsWire.Com, July 31, 2017 ) Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021-Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust GrowthDiabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia-high...
(PharmaNewsWire.Com, July 31, 2017 ) Breast Cancer Therapeutics in Asia-Pacific Markets to 2021-Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising PrevalenceBreast cancer, a malignant neoplasm, is the second-most common cancer and the most common cancer in women worldwide,...
(PharmaNewsWire.Com, July 31, 2017 ) Frontier Pharma: Breast Cancer-First-in-Class Innovation Clustered Around Growth Factor Signalling ProcessesThe Breast Cancer pipeline is the largest in the pharmaceutical industry, with 1,050 products in active development across all stages. The range of mechanisms...
(PharmaNewsWire.Com, July 29, 2017 ) Alzheimer's Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first occur in patients in their mid-sixties, appearing in varying stages....
(PharmaNewsWire.Com, July 31, 2017 ) Publisher's, "Folic Acid Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Folic Acid Antagonists. The Publisher's Report covers the product profiles in various stages of...
(PharmaNewsWire.Com, July 31, 2017 ) "Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor (FGFR) Agonists. The Report covers the product profiles...
(PharmaNewsWire.Com, July 31, 2017 ) Publisher's, "Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor 1 (FGF-1) Inhibitors. The Publisher's Report covers...
(PharmaNewsWire.Com, July 31, 2017 ) Publisher's, "Fatty Acid Synthesis Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fatty Acid Synthesis Inhibitors. The Publisher's Report covers the product profiles in...
(PharmaNewsWire.Com, July 29, 2017 ) " Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia). The Report...
(PharmaNewsWire.Com, July 29, 2017 ) Publisher's, "Factor IX A Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Factor IX A Inhibitors. The Publisher's Report covers the product profiles in various stages of...
(PharmaNewsWire.Com, July 29, 2017 ) Publisher's, "Factor IIa (Thrombin) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Factor IIa (Thrombin) Inhibitors. The Publisher's Report covers the product profiles in...
(PharmaNewsWire.Com, July 29, 2017 ) Publisher Drug Report, "Eviplera- Drug Insights, 2016" highlights the Eviplera marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Eviplera covering the...
(PharmaNewsWire.Com, July 29, 2017 ) Report, "Esophagitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Esophagitis...
(PharmaNewsWire.Com, July 29, 2017 ) Many people get out of breath quickly after starting to work out, experience muscle fatigue, and subsequently exercise less than they did previously creating a vicious cycle. We suggest that the oxygen and carbon dioxide concentrations can quickly get out of...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
